資源描述：
《1例老年患者支氣管擴(kuò)張合并感染伴心衰的藥學(xué)監(jiān)護(hù)醫(yī)學(xué)論文》由會員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫。
1、1例老年患者支氣管擴(kuò)張合并感染伴心衰的藥學(xué)監(jiān)護(hù)劉冰冰1,2（1中國醫(yī)科大學(xué)附屬盛京醫(yī)院，藥學(xué)部，2阜新礦業(yè)集團(tuán)總醫(yī)院，藥劑科，）劉曉東（1中國醫(yī)科大學(xué)附屬盛京醫(yī)院，藥學(xué)部，）【摘要】目的探討臨床藥師參與臨床治療中，如何最大限度地發(fā)揮藥物的臨床療效及盡早發(fā)現(xiàn)藥物不良反應(yīng)，促進(jìn)臨床合理用藥。方法臨床藥師全程參與一例支氣管擴(kuò)張合并感染伴心功能不全患者的臨床治療過程，對臨床給藥方案進(jìn)行分析和概述，監(jiān)測患者病情及易因藥物產(chǎn)生異常的檢查指標(biāo)，預(yù)防并及時(shí)處理藥物相關(guān)不良反應(yīng)。結(jié)果抗感染治療中，根據(jù)患者病情先后給予美羅培南，左氧氟沙星，依替米星和頭孢曲松他唑巴坦治療。同時(shí)監(jiān)測患者的肝腎功能，及時(shí)發(fā)
2、現(xiàn)患者出現(xiàn)的轉(zhuǎn)氨酶異常，并給予保肝治療。警惕依替米星可能出現(xiàn)的不良反應(yīng)。協(xié)助臨床醫(yī)生合理制定治療心衰藥物的選用與劑量調(diào)整。并對患者進(jìn)行健康教育。結(jié)論臨床藥師參與治療時(shí)及時(shí)發(fā)現(xiàn)問題，尋找臨床藥學(xué)監(jiān)護(hù)點(diǎn)，為患者提供個(gè)體化治療方案，提高用藥合理與用藥安全，體現(xiàn)臨床藥師在參與藥物治療中的積極作用?！娟P(guān)鍵字】臨床藥師藥學(xué)監(jiān)護(hù)支氣管擴(kuò)張合并感染心功能不全PharmaceuticalcareofthecaseofelderlypatientswithbronchiectasiswithinfectionwithheartfailureLiuBingbing1,2(1ChinaMedicalUni
3、versityShengjingHospital,DepartmentofPharmacy,2GeneralHospitalofFuxinMiningGroup,DepartmentofPharmacy,)LiuXiaodong(ChinaMedicalUniversityShengjingHospital,DepartmentofPharmacy,)[Abstract]ObjectiveToinvestigatetheclinicalpharmacistparticipationinclinicaltreatment,howtomaximizetheclinicalefficac
4、yofthedrugandtheearlydetectionofadversedrugreactions,promoteclinicalrationaldruguse.Methodsclinicalpharmacistsinvolvedthroughoutonecaseofbronchiectasiswithinfectionwithcardiacdysfunctionpatient'sclinicalcourseoftreatment,analysisandoverviewoftheclinicaldosingregimen,monitoringthepatient'scondi
5、tionandabnormalcheckindicatorsvulnerabletodrugpreventionandtimelytreatmentofdrug-relatedadversereaction.ResultsInanti-infectiontreatment,accordingtothepatient'sconditionhas10givenmeropenem,levofloxacin,dependingonthebehalfofmetersStarsandceftriaxonetazobactamtreatment.Whilemonitoringthepatient
6、'sliverandkidneyfunction,todetectpatientswithtransaminaseabnormalities,andgivethelivertreatment.Thevigilanceadversereactionsmayoccuretimicin.Assistcliniciansinestablishingreasonabletreatmentofheartfailuredrugselectionanddosageadjustment.Andpatientswithhealtheducation.ConclusionsClinicalpharmac
7、istsinvolvedinthetreatmentoftheproblemtofindthepointofclinicalpharmaceuticalcaretoprovideindividualizedtreatmentplanforpatients,improvemedicationreasonablyandmedicationsafety,reflectsthepositiveroleoftheclinicalpharmacisttoparticipatein
